Abiomed
ABMD
#1118
Rank
NZ$28.76 B
Marketcap
$637.94
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Cash on Hand

Cash on Hand as of September 2022 : NZ$1.37 Billion

According to Abiomed's latest financial reports the company has NZ$1.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Abiomed - Cash on Hand chart (from 2013 to 2022)

Cash on Hand by year

Year Cash on Hand Change
2022-03-31NZ$1.08 B30.37%
2021-03-31NZ$0.83 B13.21%
2020-03-31NZ$0.73 B2%
2019-03-31NZ$0.72 B44.48%
2018-03-31NZ$0.50 B52.39%
2017-03-31NZ$0.32 B6.88%
2016-03-31NZ$0.30 B74.62%
2015-03-31NZ$0.17 B99.15%
2014-03-31NZ$88.33 M-3.59%
2013-03-31NZ$91.62 M-2.6%
2012-03-31NZ$94.07 M18.87%
2011-03-31NZ$79.14 M-3.97%
2010-03-31NZ$82.41 M-19.26%
2009-03-31NZ$0.10 B109.19%
2008-03-31NZ$48.79 M-53.53%
2007-03-31NZ$0.10 B109.03%
2006-03-31NZ$50.22 M-13.78%
2005-03-31NZ$58.25 M42.13%
2004-03-31NZ$40.98 M-58.32%
2003-03-31NZ$98.33 M-39.24%
2002-03-31NZ$0.16 B-30.52%
2001-03-31NZ$0.23 B8.33%
2000-03-31NZ$0.21 B532.71%
1999-03-31NZ$33.98 M-28.88%
1998-03-31NZ$47.78 M254.63%
1997-03-31NZ$13.47 M-13.31%
1996-03-31NZ$15.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.40 B-70.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.87 B 255.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.21 B-84.11%๐Ÿ‡บ๐Ÿ‡ธ USA